The aggregation of amyloid P peptide (AP) into its fibrillar, cross P-pleated configuration is generally viewed as a critical event in the pathophysiology of Alzheimer's disease (AD). A diverse group of molecules, the AP binding proteins, has been evaluated for their effects on this process. However
Quantifying Amyloid β-Peptide (Aβ) Aggregation Using the Congo Red-Aβ (CR–Aβ) Spectrophotometric Assay
✍ Scribed by William E. Klunk; Robert F. Jacob; R.Preston Mason
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 148 KB
- Volume
- 266
- Category
- Article
- ISSN
- 0003-2697
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
DNA could readily associate with the aggregated forms of the -amyloid peptides (1-40) and (25-35), giving rise to a shift in the electrophoretic mobility of DNA. As a result, DNA was retained at the top of a 1% agarose gel. In contrast, the electrophoretic mobility of DNA was little influenced by
## Abstract We tested directly the differences in the aggregation kinetics of three important β amyloid peptides, the full‐length Aβ1‐42, and the two N‐terminal truncated and pyroglutamil modified Aβ__py__3‐42 and Aβ__py__11‐42 found in different relative concentrations in the brains in normal agin
Substantial genetic and biochemical evidence implicates amyloid peptides (A) in the etiology of Alzheimer's Disease (AD). Recent evidence indicates that A1-42 is the predominant species in the hallmark senile amyloid plaque of AD. Furthermore, A1-42 forms aggregates inside lysosomes of cultured n